+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
SYNGENE

Syngene International Share Price

 
42.71% Fall from 52W High

 

Syngene International live price: ₹417.45. It opened at ₹421 vs previous close ₹419; intraday high/low: ₹421/₹410. The 50 & 200 DMA stand at ₹437.40/₹507.20.

Syngene International Performance

  • Today's Low
  • ₹410
  • Today's High
  • ₹421
  • 52 Week Low
  • ₹380
  • 52 Week High
  • ₹729
  • Open Price₹421
  • Previous Close₹419
  • Volume502,020
  • 50 DMA₹437.40
  • 100 DMA₹456.80
  • 200 DMA₹507.20

Syngene International Chart

Investment Returns

  • Over 1 Month -6.88%
  • Over 3 Month -4.39%
  • Over 6 Month -33.43%
  • Over 1 Year -37.73%

Smart Investing Starts Here Start SIP with Syngene International for Steady Growth!

Invest Now

Syngene International Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 53.2
  • PEG Ratio
  • -1.5
  • Market Cap Cr
  • 16,851
  • P/B Ratio
  • 3.5
  • Average True Range
  • 12.6
  • EPS
  • 7.8
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -7.4
  • RSI
  • 39
  • MFI
  • 54.02

Latest Stock News Updates

Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Change in Management

Change in Senior Managerial Personnel

Syngene International Ltd - 539268 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

Syngene FY26 profit falls 20%, revenue rises 3%

Annual report attributes decline to destocking by its largest biologics manufacturing client

Syngene International Financials

Syngene International Technicals

EMA & SMA

Current Price
₹417.45
-1.95 (-0.46%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹427.90
  • 50 Day
  • ₹437.40
  • 100 Day
  • ₹456.80
  • 200 Day
  • ₹507.20

Resistance and Support

416.15 Pivot Speed
  • R3 433.00
  • R2 427.00
  • R1 422.20
  • S1 411.40
  • S2 405.40
  • S3 400.60

Syngene International Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-29 Quarterly Results
2026-04-29 Audited Results & Final Dividend
2026-01-22 Quarterly Results
2025-11-05 Quarterly Results
2025-07-23 Quarterly Results
Date Purpose Remarks
2026-06-26 FINAL Rs.1.25 per share(12.5%)Final Dividend
2025-06-27 FINAL Rs.1.25 per share(12.5%)Final Dividend
2024-06-28 FINAL Rs.1.25 per share(12.5%)Final Dividend
2023-06-30 FINAL Rs.0.50 per share(5%)Final Dividend
2022-07-01 FINAL Rs.0.50 per share(5%)Final Dividend
View Syngene International Dividend History Arrow

Syngene International Shareholding Pattern

52.59%
25.78%
11.82%
7.15%
2.23%

About Syngene International

Syngene International is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Syngene’s services include integrated drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services. View More
  • NSE Symbol
  • SYNGENE
  • BSE Symbol
  • 539268
  • Executive Director,Managing Director,Chief Executive Officer
  • Peter John Bains
  • ISIN
  • INE398R01022

Similar Stocks to Syngene International

Syngene International FAQs

Syngene International share price is ₹417 As on 19 July, 2026 | 01:48

The Market Cap of Syngene International is ₹16851.2 Cr As on 19 July, 2026 | 01:48

The P/E ratio of Syngene International is 53.2 As on 19 July, 2026 | 01:48

The PB ratio of Syngene International is 3.5 As on 19 July, 2026 | 01:48

The 52 week High & Low of Syngene International is ₹728.6/₹380 respectively As on 19 July, 2026 | 01:48

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23